CD5 and B-cell chronic lymphocytic leukemia: Similarly, the CD5 antigen has been reported to be highly expressed in CLL patients (Bashford-Rogers et al., 2017), and we also found that it was hypomethylated in promoter and body regions and highly expressed in CLL cases.